CN1112439A - Chinese medicine for diabetes and its preparation - Google Patents
Chinese medicine for diabetes and its preparation Download PDFInfo
- Publication number
- CN1112439A CN1112439A CN 95103732 CN95103732A CN1112439A CN 1112439 A CN1112439 A CN 1112439A CN 95103732 CN95103732 CN 95103732 CN 95103732 A CN95103732 A CN 95103732A CN 1112439 A CN1112439 A CN 1112439A
- Authority
- CN
- China
- Prior art keywords
- blood sugar
- sugar lowering
- medicated powder
- happy
- chinese medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 206010012601 diabetes mellitus Diseases 0.000 title claims abstract description 27
- 239000003814 drug Substances 0.000 title claims description 89
- 238000002360 preparation method Methods 0.000 title abstract description 4
- 239000000843 powder Substances 0.000 claims abstract description 118
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 56
- 210000000496 pancreas Anatomy 0.000 claims abstract description 22
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 18
- 235000009854 Cucurbita moschata Nutrition 0.000 claims abstract description 12
- 235000000832 Ayote Nutrition 0.000 claims abstract description 11
- 235000009804 Cucurbita pepo subsp pepo Nutrition 0.000 claims abstract description 11
- 235000015136 pumpkin Nutrition 0.000 claims abstract description 11
- 240000001980 Cucurbita pepo Species 0.000 claims abstract 3
- 239000009636 Huang Qi Substances 0.000 claims description 19
- 238000004519 manufacturing process Methods 0.000 claims description 15
- 239000002775 capsule Substances 0.000 claims description 14
- 238000001035 drying Methods 0.000 claims description 13
- 241000283690 Bos taurus Species 0.000 claims description 11
- 239000000203 mixture Substances 0.000 claims description 11
- 241000282898 Sus scrofa Species 0.000 claims description 10
- 239000003826 tablet Substances 0.000 claims description 7
- 241000283898 Ovis Species 0.000 claims description 6
- 241001494479 Pecora Species 0.000 claims description 6
- 239000000284 extract Substances 0.000 claims description 6
- 239000000706 filtrate Substances 0.000 claims description 5
- 238000001914 filtration Methods 0.000 claims description 4
- 230000002421 anti-septic effect Effects 0.000 claims description 3
- 238000007598 dipping method Methods 0.000 claims description 3
- 239000002075 main ingredient Substances 0.000 claims description 3
- 230000001954 sterilising effect Effects 0.000 claims description 3
- 238000004659 sterilization and disinfection Methods 0.000 claims description 3
- 239000012567 medical material Substances 0.000 claims description 2
- 239000002674 ointment Substances 0.000 claims description 2
- 238000010298 pulverizing process Methods 0.000 claims 1
- 210000004369 blood Anatomy 0.000 abstract description 155
- 239000008280 blood Substances 0.000 abstract description 155
- 241001465754 Metazoa Species 0.000 abstract description 64
- 230000000694 effects Effects 0.000 abstract description 37
- 230000001737 promoting effect Effects 0.000 abstract description 7
- 241000045403 Astragalus propinquus Species 0.000 abstract description 5
- 235000006533 astragalus Nutrition 0.000 abstract description 5
- 239000000463 material Substances 0.000 abstract description 5
- 230000003914 insulin secretion Effects 0.000 abstract description 4
- 235000005903 Dioscorea Nutrition 0.000 abstract 2
- 241000234273 Dioscorea Species 0.000 abstract 2
- 235000000504 Dioscorea villosa Nutrition 0.000 abstract 2
- 235000014443 Pyrus communis Nutrition 0.000 abstract 2
- 235000004879 dioscorea Nutrition 0.000 abstract 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 67
- 239000008103 glucose Substances 0.000 description 67
- 241000196324 Embryophyta Species 0.000 description 55
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 52
- 102000004877 Insulin Human genes 0.000 description 26
- 108090001061 Insulin Proteins 0.000 description 26
- 229940125396 insulin Drugs 0.000 description 26
- 239000012153 distilled water Substances 0.000 description 25
- 238000000465 moulding Methods 0.000 description 25
- 150000001720 carbohydrates Chemical class 0.000 description 22
- 235000014633 carbohydrates Nutrition 0.000 description 22
- 229940079593 drug Drugs 0.000 description 19
- HIMXGTXNXJYFGB-UHFFFAOYSA-N alloxan Chemical compound O=C1NC(=O)C(=O)C(=O)N1 HIMXGTXNXJYFGB-UHFFFAOYSA-N 0.000 description 16
- 239000000243 solution Substances 0.000 description 16
- ICFJFFQQTFMIBG-UHFFFAOYSA-N phenformin Chemical compound NC(=N)NC(=N)NCCC1=CC=CC=C1 ICFJFFQQTFMIBG-UHFFFAOYSA-N 0.000 description 14
- 241000700159 Rattus Species 0.000 description 13
- 235000012054 meals Nutrition 0.000 description 13
- 238000000034 method Methods 0.000 description 13
- 229960004580 glibenclamide Drugs 0.000 description 12
- ZNNLBTZKUZBEKO-UHFFFAOYSA-N glyburide Chemical compound COC1=CC=C(Cl)C=C1C(=O)NCCC1=CC=C(S(=O)(=O)NC(=O)NC2CCCCC2)C=C1 ZNNLBTZKUZBEKO-UHFFFAOYSA-N 0.000 description 12
- 208000024891 symptom Diseases 0.000 description 12
- 241000699670 Mus sp. Species 0.000 description 11
- 241000699666 Mus <mouse, genus> Species 0.000 description 10
- 240000004244 Cucurbita moschata Species 0.000 description 9
- 230000006870 function Effects 0.000 description 9
- 206010036067 polydipsia Diseases 0.000 description 9
- 238000012360 testing method Methods 0.000 description 9
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 8
- 201000010099 disease Diseases 0.000 description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- 201000001421 hyperglycemia Diseases 0.000 description 8
- 210000000952 spleen Anatomy 0.000 description 8
- 210000002700 urine Anatomy 0.000 description 8
- 230000027939 micturition Effects 0.000 description 7
- 230000007812 deficiency Effects 0.000 description 6
- 230000003203 everyday effect Effects 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 6
- 210000004072 lung Anatomy 0.000 description 6
- 210000002966 serum Anatomy 0.000 description 6
- 230000035922 thirst Effects 0.000 description 6
- 210000001124 body fluid Anatomy 0.000 description 5
- 239000010839 body fluid Substances 0.000 description 5
- 235000009508 confectionery Nutrition 0.000 description 5
- 238000003745 diagnosis Methods 0.000 description 5
- 230000003345 hyperglycaemic effect Effects 0.000 description 5
- 230000001225 therapeutic effect Effects 0.000 description 5
- 230000002485 urinary effect Effects 0.000 description 5
- 208000004880 Polyuria Diseases 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 206010016256 fatigue Diseases 0.000 description 4
- 230000036039 immunity Effects 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 230000001717 pathogenic effect Effects 0.000 description 4
- 230000000144 pharmacologic effect Effects 0.000 description 4
- 229940002612 prodrug Drugs 0.000 description 4
- 239000000651 prodrug Substances 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 230000001502 supplementing effect Effects 0.000 description 4
- 206010067484 Adverse reaction Diseases 0.000 description 3
- 206010013954 Dysphoria Diseases 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 206010037660 Pyrexia Diseases 0.000 description 3
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 3
- 230000006838 adverse reaction Effects 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 230000037396 body weight Effects 0.000 description 3
- 230000006837 decompression Effects 0.000 description 3
- 238000009826 distribution Methods 0.000 description 3
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 238000003304 gavage Methods 0.000 description 3
- 206010022437 insomnia Diseases 0.000 description 3
- 230000010354 integration Effects 0.000 description 3
- 238000010791 quenching Methods 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 230000035807 sensation Effects 0.000 description 3
- 235000019615 sensations Nutrition 0.000 description 3
- 235000010199 sorbic acid Nutrition 0.000 description 3
- 239000004334 sorbic acid Substances 0.000 description 3
- 229940075582 sorbic acid Drugs 0.000 description 3
- 238000012795 verification Methods 0.000 description 3
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 description 2
- 206010033557 Palpitations Diseases 0.000 description 2
- 241000282894 Sus scrofa domesticus Species 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 210000005252 bulbus oculi Anatomy 0.000 description 2
- 229930185803 charantin Natural products 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 210000002808 connective tissue Anatomy 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 230000001976 improved effect Effects 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 239000002547 new drug Substances 0.000 description 2
- 229940100691 oral capsule Drugs 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- 235000010241 potassium sorbate Nutrition 0.000 description 2
- 239000004302 potassium sorbate Substances 0.000 description 2
- 229940069338 potassium sorbate Drugs 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 230000002269 spontaneous effect Effects 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 235000019640 taste Nutrition 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- 238000003809 water extraction Methods 0.000 description 2
- WSWCOQWTEOXDQX-MQQKCMAXSA-M (E,E)-sorbate Chemical compound C\C=C\C=C\C([O-])=O WSWCOQWTEOXDQX-MQQKCMAXSA-M 0.000 description 1
- BOVGTQGAOIONJV-BETUJISGSA-N 1-[(3ar,6as)-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-2-yl]-3-(4-methylphenyl)sulfonylurea Chemical compound C1=CC(C)=CC=C1S(=O)(=O)NC(=O)NN1C[C@H]2CCC[C@H]2C1 BOVGTQGAOIONJV-BETUJISGSA-N 0.000 description 1
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 1
- RKWGIWYCVPQPMF-UHFFFAOYSA-N Chloropropamide Chemical compound CCCNC(=O)NS(=O)(=O)C1=CC=C(Cl)C=C1 RKWGIWYCVPQPMF-UHFFFAOYSA-N 0.000 description 1
- 108090000317 Chymotrypsin Proteins 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 235000002722 Dioscorea batatas Nutrition 0.000 description 1
- 235000006536 Dioscorea esculenta Nutrition 0.000 description 1
- 240000001811 Dioscorea oppositifolia Species 0.000 description 1
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 description 1
- 102000051325 Glucagon Human genes 0.000 description 1
- 108060003199 Glucagon Proteins 0.000 description 1
- 108010015776 Glucose oxidase Proteins 0.000 description 1
- 239000004366 Glucose oxidase Substances 0.000 description 1
- 206010020710 Hyperphagia Diseases 0.000 description 1
- 206010061245 Internal injury Diseases 0.000 description 1
- 108060005987 Kallikrein Proteins 0.000 description 1
- 102000001399 Kallikrein Human genes 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 239000004283 Sodium sorbate Substances 0.000 description 1
- JLRGJRBPOGGCBT-UHFFFAOYSA-N Tolbutamide Chemical compound CCCCNC(=O)NS(=O)(=O)C1=CC=C(C)C=C1 JLRGJRBPOGGCBT-UHFFFAOYSA-N 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 210000004404 adrenal cortex Anatomy 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000002605 anti-dotal effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 239000007963 capsule composition Substances 0.000 description 1
- 230000023852 carbohydrate metabolic process Effects 0.000 description 1
- 235000021256 carbohydrate metabolism Nutrition 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 229960002376 chymotrypsin Drugs 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- -1 elastoser Proteins 0.000 description 1
- 230000007159 enucleation Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 210000000887 face Anatomy 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- MASNOZXLGMXCHN-ZLPAWPGGSA-N glucagon Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 MASNOZXLGMXCHN-ZLPAWPGGSA-N 0.000 description 1
- 229960004666 glucagon Drugs 0.000 description 1
- 229940116332 glucose oxidase Drugs 0.000 description 1
- 235000019420 glucose oxidase Nutrition 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 229960003444 immunosuppressant agent Drugs 0.000 description 1
- 230000001861 immunosuppressant effect Effects 0.000 description 1
- 239000003018 immunosuppressive agent Substances 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000002608 insulinlike Effects 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 231100000682 maximum tolerated dose Toxicity 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- XZWYZXLIPXDOLR-UHFFFAOYSA-N metformin Chemical compound CN(C)C(=N)NC(N)=N XZWYZXLIPXDOLR-UHFFFAOYSA-N 0.000 description 1
- 229960003105 metformin Drugs 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 229940100690 oral cream Drugs 0.000 description 1
- 238000007410 oral glucose tolerance test Methods 0.000 description 1
- 229940096978 oral tablet Drugs 0.000 description 1
- 239000007935 oral tablet Substances 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 229940023462 paste product Drugs 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 230000001817 pituitary effect Effects 0.000 description 1
- 208000022530 polyphagia Diseases 0.000 description 1
- 230000000291 postprandial effect Effects 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 208000037821 progressive disease Diseases 0.000 description 1
- 208000018299 prostration Diseases 0.000 description 1
- 230000022558 protein metabolic process Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000011555 rabbit model Methods 0.000 description 1
- 230000000384 rearing effect Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 210000003705 ribosome Anatomy 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 229920002477 rna polymer Polymers 0.000 description 1
- 238000013077 scoring method Methods 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- LROWVYNUWKVTCU-STWYSWDKSA-M sodium sorbate Chemical compound [Na+].C\C=C\C=C\C([O-])=O LROWVYNUWKVTCU-STWYSWDKSA-M 0.000 description 1
- 235000019250 sodium sorbate Nutrition 0.000 description 1
- 229940075554 sorbate Drugs 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 238000012109 statistical procedure Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 229960005371 tolbutamide Drugs 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
A preparation for diabetes consists of animal pancreas, balsom pear, pumpkin, root of astragalus membranaceus and rhizome of dioscorea, in which the pancreas is smashed and dried, balsom pear, pumpkin and root of astragalus membranaceus are extracted with water or alcohol, then the materials are mixed with the dioscorea powder, and has effect of improving immunocompetence, promoting insulin secretion and reducing the blood sugar.
Description
The present invention relates to a kind of production method for the treatment of Chinese medicine and this Chinese medicine thereof of diabetes.
Diabetes are a kind of whole body chronic progressive diseases, modern medicine thinks that its cause of disease is because pancreatic secretion, the absolute shortage of insulin or relative deficiency and due to the carbohydrate metabolism disturbance that causes, so at its etiological study with released many Western medicine, as metformin, diamicron, plain tablet of Chlorpropamidum and insulin injection etc., the weak point that these Western medicine exist is a complex manufacturing, cost is higher, and Western medicine is temporary transient blood sugar lowering for the effect for the treatment of diabetes mostly, can not effect a radical cure, the side effect in addition that has, many people rely on Western medicine and injection for a long time, development that can not disease controlling, in case disconnected medicine, blood glucose again can very fast risings, the dose of use is increasing.
China's tradition Chinese medicine also had many records to diabetes (diabetes), think that the symptom that diabetes occur is that thirsty polydipsia, rapid digestion of food are easily hungry, frequent micturition and sweet, body sees gradually and becomes thin that reason is YIN fluid deficiency, production of dryness-heat in the interior, is this with the deficiency of YIN, scorching for marking, also adopted some prescriptions and therapeutic scheme in some Chinese medicine handbooks and Chinese medicine textbook, but some compatibility of medicines in a prescription are reasonable not enough, effect is not satisfactory.
The purpose of this invention is to provide and a kind ofly make, can prevent, control, support medicine and this medicine production method of three bonded effective treatment diabetes with natural Chinese medicine.
The present invention is the proved recipe that treatment of diabetes basis is proposed according to Chinese medicine and makes a kind of Chinese patent medicine that its composition and content, production method, the mechanism of action and clinical practice are discussed below:
One, Main Ingredients and Appearance and content (by dried medical material weight %):
The pancreas 20-45 of pig or cattle, sheep
Fructus Momordicae charantiae 18-32
Rhizoma Dioscoreae 10-28
Fructus Cucurbitae moschatae 15-25
Radix Astragali 10-26
Two, production method
1, the pancreas of getting pig or cattle, sheep is cleaned, and removes fat and connective tissue, rubs with meat grinder, in 50-80 ℃ of drying under reduced pressure, is ground into powder again, and is standby.
2, get dried Frutus Momordicae Charantiae, dried pumpkin, Radix Astragali chopping, mix, employing water extraction or separating out alcohol method extraction active ingredient are called water extract or alcohol is analysed thing, and water extraction is mixture to be added water 5-6 doubly earlier, soaked 4-8 hour, decoct secondary, each 1 hour, collecting decoction, filter, filtrate is evaporated to the clear paste that relative density is 1.2-1.4 60-80 ℃ temperature.Separating out alcohol method is that the solution that leaches steams ethanol, obtains the solution I with mixture alcohol solution dipping 4-10 hour with 2-3 70-80% doubly; Filtering residue discards residue with 2 times of water boils 1 hour, obtains the solution II, and solution I and solution II are merged, and is evaporated to the clear paste that relative density is 1.2-1.4.
3, get Rhizoma Dioscoreae clean, dry, be ground into middle powder after expanded, standby.
4, getting the above-mentioned pig that makes, cattle, Pancreas caprae seu ovis powder mixes with spissated clear paste and Rhizoma Dioscoreae powder, the antiseptic such as sorbic acid or the sorbate etc. that add 0.3-0.5%, stir, the low-temperature reduced-pressure drying, pulverize 100 mesh sieves, sterilization, made tablet or capsule, obtained product (declaration nomenclature of drug " blood sugar lowering is happy "), also can be with pig, cattle, Pancreas caprae seu ovis powder, Rhizoma Dioscoreae powder, the extracting solution of an amount of antiseptic and dried pumpkin, dried Frutus Momordicae Charantiae, the Radix Astragali is made the paste product.
Three, usage
Take above-mentioned " blood sugar lowering happy " tablet that makes or electuary, unguentum for the patient of diabetes after diagnosing, each 2-4 gram, every day 3-4 time, pass through provincial hospital and medical university's clinical verification, prove that this Chinese patent medicine has supplementing QI for promoting the production of body fluid, spleen invigorating is moisturized, the taste lung reinforces the kidney, the function of nourishing YIN to lower pathogenic fire has significant blood sugar lowering effect.
Four, the present invention " blood sugar lowering happy " prevents and treats diabetes mechanism
1, the pancreas of animal pancreas, particularly pig, cattle, sheep, the property sugariness is flat, has nourishing yin and moistening dryness.In the Compendium of Material Medica that Ming Dynasty's Li Shizhen (1518-1593 A.D.) is shown, once introduced the effect that to treat diabetes, the meaning that " dirty with dirty benefit " arranged, the modern biochemistry analysis result, be rich in trypsin, Chymotrypsin in the animal pancreas, kallikrein, elastoser, glucagon isoreactivity composition so Chinese medicine of the present invention is Main Ingredients and Appearance with the animal pancreas, can play the effect of treatment diabetes.
2, (China's the South and the North all has cultivation to Fructus Momordicae charantiae, go into greengrocery), its bitter in the mouth is cold in nature, clearing away heat-fire is arranged, the Detoxication of promoting the production of body fluid, analyze the Charantin that includes through the inventor similar insulin-like material is arranged, tangible blood sugar reducing function is arranged, also prove in pharmacological evaluation, rabbit normal and the alloxan hyperglycemia gavages Succus Momordicae charantiae, blood glucose is obviously reduced, the rat that subcutaneous injection anterior pituitary extractum causes hyperglycemia, the water extract that gavages Succus Momordicae charantiae also has the blood sugar lowering effect, but gives the oral Charantin blood sugar lowering of rabbit model of action similar to tolbutamide and stronger, so the present invention as accessory drugs, acts on bigger with Fructus Momordicae charantiae.
3, Fructus Cucurbitae moschatae, cucurbitaceous plant (Cucurbita moschata), sweet in the mouth, warm in nature, invigorating the spleen and replenishing QI is arranged, the effect of anti-inflammatory analgetic and promotion insulin secretion, the inventor analyzes, be rich in trace element cobalt in the Fructus Cucurbitae moschatae, can make insulin secretion normal, diabetics is produced effect, in medicine, add and to play the collaborative blood sugar reducing function that strengthens, and the tonification effect of Fructus Cucurbitae moschatae, can enhancing human body immunity function, add and be used as medicine, play auxiliary principal agent performance pharmacological action.
4, Rhizoma Dioscoreae, have another name called Rhizomadioscoreae, nature and flavor are sweet flat, tool spleen invigorating, tonifying the lung, reinforce the kidney the merit of benefit essence, disease such as control diarrhea due to hypofunction of the spleen, chronic dysentery, asthenia, quench one's thirst, modern pharmacological research shows that the Chinese yam polysaccharide composition is in methanol one water, and extract can play the effect that reduces mouse blood sugar concentration.
5, the Radix Astragali, Radix Astragali beginning is stated from Shennong's Herbal, nature and flavor are sweet, tepor, nontoxic, go into lung, spleen channel, and benefit defends consolidating superficial resistance, inducing diuresis to remove edema, detoxification, functions such as granulation promoting, disease such as control spontaneous perspiration, blood low, floating lung, internal injury strain, deficiency of vital energy blood prostration, quench one's thirst.Modern study shows, the Radix Astragali and polysaccharide, can resist immunosuppressant, the immunologic function of activate immunity organ significantly improves antibody forming cell's number, strengthen humoral immune function, enhancing antibody is synthetic, promotes nucleus ribosomal ribonucleic acid and protein metabolism, can improve the content of secreting type immune protein A, stimulate lymphocyte transformation, improve adrenal cortex function.
Though the Radix Astragali hot dryness-fire warm in nature.But add the bitter cold of Fructus Momordicae charantiae antidotal restriction is arranged in being used as medicine, thereby avoid the scorching fraud of the Radix Astragali, help to make the property of medicine gentle, obey for a long time and do not have a hot side effect.
The present invention has supplementing QI for promoting the production of body fluid through selected above-mentioned five tastes medicine, and spleen invigorating is moisturized, the nourishing YIN to lower pathogenic fire effect, and the human body immunity improving function is arranged, promote insulin secretion, the effect of blood sugar lowering.Compare with Western medicine, Western medicine is blood sugar lowering and the interim interior insulin of body that increases temporarily, can not impel the function of pancreas itself to improve, and promptly a lot of Western medicine can only take stopgap measures, and can not effect a permanent cure.And the present invention can take stopgap measures, and can effect a permanent cure again.And medicine composition of the present invention is natural materials, and the source is wide, and cost is low, medicine-food two-purpose, no side effects.
Five, embodiments of the invention:
1, medicine pretreatment
Get pig, cattle, the Pancreas caprae seu ovis, clean of fresh or refrigerated no pathological changes, remove fat and connective tissue, rub,, be ground into fine powder again in 50-80 ℃ of drying under reduced pressure with meat grinder, standby.
Get fresh pumpkin, Fructus Momordicae charantiae, enucleation, thinly slice, dry or use the drying machine drying naturally.
Gather Rhizoma Dioscoreae, remove mud, cleaning, drying are ground into powder after expanded.
Gather the Radix Astragali, clean, chip drying is ground into middle powder.
2, medication preparation embodiment:
Embodiment one
Get dried pumpkin 250 grams, dried Frutus Momordicae Charantiae 220 grams, the Radix Astragali 130 grams, adding water earlier soaked 6 hours for 2 liters, decocted 1 hour, solution poured in the container stock, adding 1.5 liters in water again boiled 1 hour, solution and primary solution are mixed, be evaporated to the clear paste that relative density is 1.2-1.4, get Pancreas Sus domestica powder 250 grams, Rhizoma Dioscoreae powder 150 grams, potassium sorbate 0.3 gram (the most handy low amounts of water dissolving) and clear paste mixing, drying under reduced pressure was pulverized 100 mesh sieves, sterilized 3-5 minute, incapsulate, be " blood sugar lowering is happy " oral capsule.
Embodiment two, get dried pumpkin 200 grams, dried Frutus Momordicae Charantiae 240 grams, astragalus membranaceus powder 180 grams add 2 liters in water, soak 1 hour after-filtration of decoction in 4 hours and go out medicinal residues, add 2 premium on currency again and boil 1 hour collecting decoction, filtrate decompression is concentrated into the clear paste that relative density is 1.2-1.4, and other gets Pancreas Bovis seu Bubali powder 280 grams, Rhizoma Dioscoreae powder 100 grams, sorbic acid 0.35 gram, with the clear paste mixing, drying under reduced pressure, pulverize, sieve, sterilize 5 minutes, be pressed into tablet, be " blood sugar lowering happy " oral tablet.
Embodiment three, get dried pumpkin 150 grams, dried Frutus Momordicae Charantiae 180 grams, the Radix Astragali 180 grams, the method for pressing embodiment one and embodiment two is soaked the back and is decocted at twice with 3 premium on currency, the filtrate decompression that merges is concentrated into the clear paste that relative density is 1.2-1.4, gets Pancreas caprae seu ovis powder 350 grams again, Rhizoma Dioscoreae powder 140 grams, potassium sorbate 0.4 gram (the most handy low amounts of water dissolving) is with clear paste mix homogeneously, drying under reduced pressure, pulverized 100 mesh sieves, sterilized 3 minutes, and incapsulated, obtain " blood sugar lowering is happy " oral capsule.
Embodiment four, get dried pumpkin 170 grams, dried Frutus Momordicae Charantiae 280 grams, astragalus mongholicus tablet or powder 220 grams add 3.5 liters in water, decoct at twice as stated above, filtrate decompression is concentrated into the clear paste that relative density is 1.2-1.4, gets Pancreas Sus domestica powder 240 grams again, Rhizoma Dioscoreae powder 100 grams, sodium sorbate 0.5 gram, with the clear paste mixing, put into vial, seal, sterilization gets " blood sugar lowering is happy " oral cream.
Embodiment five, get dried pumpkin 180 gram, dried Frutus Momordicae Charantiae 250 grams, and astragalus mongholicus tablet 200 grams, chopping, with 1.5 liter 75% alcohol solution dipping 5 hours, the solution that leaches steamed ethanol earlier, and (ethanol is recyclable) obtains the solution I; Filtering residue boiled 1 hour with 2 premium on currency, discarded residue, obtained the solution II, and solution I and solution II are merged, be evaporated to the clear paste that relative density is 1.2-1.4, get Pancreas Bovis seu Bubali powder 220 grams again, Rhizoma Dioscoreae powder 110 grams, sorbic acid 0.4 gram, with clear paste mixing, drying under reduced pressure, pulverize, make capsule.
Six, the test of medicine of the present invention and clinical
1. pharmacodynamics test
Guangxi treatment and prevention of tumour institute in the May, 1994-intend June with the happy treatment of blood sugar lowering diabetes, clinical consumption is each 4 capsules, 3 times on the one, every capsules 0.5g, TDD are 6g, with adult's weighing machine of 50kg, then its dosage is 0.12g cream/kg.d.Cure mainly and new Chinese medicine pharmacological research guide according to this medicine function, design blood sugar lowering pleasure is to the influence of intact animal and hyperglycemia model animal blood glucose, and the detection of animal carbohydrate tolerance test and serum insulin content thes contents are as follows:
A. experiment material
(1) medicine: the blood sugar lowering pleasure is made up of plant medicated powder (Fructus Momordicae charantiae, Fructus Cucurbitae moschatae, Radix Astragali water extract or alcohol are analysed thing and the composite medicated powder of Rhizoma Dioscoreae) and animal medicated powder (pig or cattle, Pancreas caprae seu ovis powder), plant medicated powder is chocolate brown powder, animal medicated powder is the taupe powder, faces to grind after the time spent, the two was mixed in proportion to be made into suspension.Insoral, Jintan, Jiangsu Province county pharmaceutical factory, lot number: 881116, glyburide, Guangzhou brilliance pharmaceutical factory, lot number: 930703.
(2) reagent: blood glucose test kit, Taiwan are marked good company limited, lot number: 40101.Glucose (A.R), reagent purchasing station, Shanghai, lot number: 7805150, insulin test kit, research institute of atomic energy sciences of the Chinese Academy of Sciences, lot number: 940810.Alloxan, this institute is synthetic.
(3) food: the BT2245-ARCD full automatic biochemical apparatus, Italy produces.The automatic r immunity of FJ-2003/50G calculating instrument, Plant No. 262.
(4) animal: NIH is a mice, and ♂ ♀ has concurrently, body weight 20 ± 2g, regular grade: SD is a rat, ♂ ♀ dual-purpose, body weight 180 ± 20g, regular grade, all available from Guangxi Chinese medicine institute animal housing,, in the Rotating Stainless Steel Cage tool, raise with pellet and put 26 ± 1 ℃ of air-conditioner temperatures by the sex sub-cage rearing, under relative temperature 60 ± 5% conditions, all animals are equal fasting 12h before getting hematometry, but can't help water.
B. experimental technique and result
(1) to the influence of normal mouse blood sugar, insulin and carbohydrate tolerance
Choose 80 of NIH mices, evenly be divided into 8 groups by sex, body weight layering, 10 every group, ♂ ♀ half and half.Establish the happy high dose group of blood sugar lowering (6g/kg.BW) respectively, low dose group (0.6g/kg, BW), animal medicated powder high dose group (4.4g powder/kg, BW), low dose group (0.4g powder/kg, BW), animal medicated powder high dose group (1.56 powder/kg.BW), low dose group (0.16 powder/kg.BW), positive controls (glyburide 50mg/kg), and blank group (distilled water 20ml/kg), the administration volume is 0.2ml/10g, BW, by above-mentioned dosage ig every day administration 1 time, continuous 10 days, 1h behind the last medicine, the eyeball rear vein beard is got blood, separation of serum is measured serum glucose value (glucose oxidase method) and insulin level (radioimmunology).After taking a blood sample, each Mus gives glucose 2.5g/kg, BW, ig measure again to after the sugar 0.5, the serum level of glucose (carbohydrate tolerance) of 1h and 2h.Other gets 80 NIM mices, as stated above, and repeated trials.2 batches of experiment glyburide can obviously reduce normal mouse blood glucose insulin level and not have significant difference as a result, see Table 1, table 2.
(2) to the influence of normal rat blood sugar, insulin and carbohydrate tolerance
Choose 80 of SD rats, the animal grouping, administrated method, dosage, observation index are all with experiment 1.Each group of result does not have obvious influence to normal rat blood sugar and insulin level.The happy high dose of blood sugar lowering, plant medicated powder high dose and the carbohydrate tolerance test of glyburide treated animal when 120min, its G/W on average significantly is lower than the distilled water group.See Table 4.Show that the blood sugar lowering pleasure can increase carbohydrate tolerance.
(3) to the influence of alloxan hyperglycemia mouse blood sugar, insulin and carbohydrate tolerance.
Choosing NIH is 120 of white mice, and ♂ surveys empty stomach 10h blood glucose 2 times, after 2 days, leaves and takes 10 mices and makes blank, the equal iv alloxan of all the other animals 80mg/kg moulding at interval.Measure blood glucose behind the moulding 48h.Choose 80 confession tests of mice that blood glucose is higher than 10mmol/L, be divided into 8 groups at random, every group 10, administrated method, dosage and observation index are with experiment 1, but positive controls gives insoral 100mg/kg.BW, successive administration 10 days, 1h behind the last medicine, the eyeball rear vein beard is got blood, and separation of serum is measured serum glucose and insulin level.Get the equal ig glucose of each treated animal 2.5g/kg.BW behind the blood, survey anti-sugar amount according to preceding method.According to the method described above, other gets 80 of the mices that blood glucose is higher than 10mmol/L, repeated trials.Administration as a result 10 days, the happy and plant amedica part of blood sugar lowering, the insulin level that can obviously raise, blood sugar lowering level (see Table 5, table 6); Happy and the plant amedica part of blood sugar lowering, the animal drugs part can obviously improve carbohydrate tolerance (seeing Table 7).
(4) to the influence of alloxan hyperglycemic rat blood glucose, insulin and carbohydrate tolerance
Choosing SD is 120 of rat, the grouping of ♂ animal, dosage approach, method and observation index are with experiment 3, but the used alloxan dosage of moulding 45mg/kg.BW, the obvious amount of the liter insulin level (table 9) of the happy and plant amedica part of blood sugar lowering, animal drugs part as a result, blood sugar lowering level (table 8), and increase carbohydrate tolerance (table 10)
Table 1 blood sugar lowering pleasure is to the influence of normal mouse blood sugar and insulin level (n ± 10, X ± SD)
Dosage blood glucose mmol/L insulin (ZU/L)
(g/kg) behind the medicine prodrug behind the medicine prodrug
A collection of:
Happy (height) 6.00 5.73 ± 1.20 5.42 ± 0.97 15.25 ± 3.67 17.07 ± 2.52 of blood sugar lowering
Happy (low) 0.60 5.80 ± 1.02 5.49 ± 1.43 15.16 ± 3.04 15.41 ± 3.32 of blood sugar lowering
Plant medicated powder (height) 4.40 6.05 ± 1.27 5.56 ± 1.15 14.61 ± 3.50 15.60 ± 3.40
Plant medicated powder (low) 0.44 6.11 ± 1.11 6.00 ± 1.06 14.89 ± 3.26 15.16 ± 3.84
Animal medicated powder (height) 1.56 5.76 ± 1.41 5.46 ± 1.04 15.52 ± 4.07 16.39 ± 3.08
Animal medicated powder (low) 0.16 5.98 ± 1.06 5.55 ± 1.00 15.31 ± 4.17 15.55 ± 3.10
Glyburide 0.05 5.59 ± 0.84 4.06 ± 1.07** 14.91 ± 4.26 14.40 ± 4.45
Distilled water 20ml 6.14 ± 1.58 5.76 ± 1.15 15.03 ± 2.40 15.24 ± 2.27
Two batches:
Happy (height) 6.00 5.805 ± 1.20 5.60 ± 1.41 13.80 ± 2.91 16.31 ± 3.30 of blood sugar lowering
Happy (low) 0.60 5.82 ± 1.02 5.63 ± 1.11 13.90 ± 2.71 14.63 ± 3.33 of blood sugar lowering
Plant medicated powder (height) 4.40 5.81 ± 0.54 6.22 ± 0.85 13.08 ± 2.61 15.33 ± 3.14
Plant medicated powder (low) 0.44 6.08 ± 1.06 5.92 ± 0.89 12.41 ± 2.45 13.51 ± 2.90
Animal medicated powder (height) 1.56 5.77 ± 0.78 5.63 ± 0.76 14.02 ± 3.04 14.21 ± 2.82
Animal medicated powder (low) 0.16 5.81 ± 0.79 5.71 ± 0.69 15.08 ± 3.31 15.73 ± 2.60
Glyburide 0.05 5.80 ± 0.44 4.22 ± 0.71** 15.22 ± 3.32 15.20 ± 2.27
Distilled water 20ml 5.66 ± 1.23 5.53 ± 1.42 14.70 ± 3.33 14.87 ± 2.90
Compare with blank group (distilled water group).**P<0.05 **P<0.01
Table 2 blood sugar lowering pleasure is to the influence of normal mouse carbohydrate tolerance (n ± 10, X ± SD)
Dosage carbohydrate tolerance (blood glucose mmol/L)
120min behind the 60min medicine behind the 20min medicine behind the g/kg medicine
A collection of
Happy (height) 6.00 6.39 ± 2.79 6.21 ± 2.52 5.48 ± 1.83 of blood sugar lowering
Happy (low) 0.60 6.53 ± 2.34 6.37 ± 2.25 5.68 ± 2.16 of blood sugar lowering
Plant medicated powder (height) 4.40 7.31 ± 1.71 6.88 ± 2.04 6.09 ± 1.45
Plant medicated powder (low) 0.44 7.89 ± 1.79 7.55 ± 1.61 6.65 ± 1.25
Animal medicated powder (height) 1.56 7.15 ± 1.48 6.48 ± 1.26 5.83 ± 0.95
Animal medicated powder (low) 0.16 8.63 ± 2.36 7.48 ± 1.60 6.63 ± 1.15
Glyburide 0.05 5.73 ± 1.03** 5.89 ± 1.20* 6.07 ± 1.56
Distilled water 20.0ml 8.27 ± 2.10 7.41 ± 1.90 6.29 ± 2.16
Two batches
Happy (height) 6.00 7.00 ± 1.30 6.80 ± 1.20 6.53 ± 1.20 of blood sugar lowering
Happy (low) 0.60 7.40 ± 1.20 7.40 ± 0.09 7.01 ± 1.61 of blood sugar lowering
Plant medicated powder (height) 4.40 7.21 ± 1.05 6.91 ± 1.20 6.81 ± 1.11
Plant medicated powder (low) 0.44 7.81 ± 1.63 7.51 ± 0.84 7.33 ± 1.12
Animal medicated powder (height) 1.56 7.32 ± 1.14 7.15 ± 1.23 7.13 ± 0.88
Animal medicated powder (low) 0.16 7.94 ± 1.16 7.43 ± 1.15 7.23 ± 1.57
Glyburide 0.05 5.40 ± 1.03*** 6.01 ± 1.31** 6.00 ± 1.02*
Distilled water 20.0ml 8.14 ± 1.23 7.93 ± 1.35 7.46 ± 1.28
Compare * P<0.05 * * P<0.01 * * * P<0.001 with blank group (distilled water group)
Table 3 blood sugar lowering pleasure is to the influence of normal rat blood sugar and insulin level (n=10, X ± SD)
Dosage blood glucose mmol/L insulin (IU/L)
(g/kg) behind the medicine prodrug behind the medicine prodrug
A collection of:
Happy (height) 6.00 4.74 ± 0.92 4.76 ± 0.76 41.36 ± 9.74 44.66 ± 11.05 of blood sugar lowering
Happy (low) 0.60 4.94 ± 0.78 5.36 ± 0.60 38.86 ± 8.85 42.81 ± 8.91 of blood sugar lowering
Plant medicated powder (height) 4.40 5.16 ± 0.67 5.34 ± 0.61 39.07 ± 9.06 41.90 ±
8.99
Plant medicated powder (low) 0.44 5.18 ± 0.99 5.36 ± 0.86 39.15 ± 9.97 43.08 ± 10.04
Animal medicated powder (height) 1.56 4.85 ± 0.95 5.27 ± 0.59 42.83 ± 10.06 43.35 ± 10.89
Animal medicated powder (low) 0.16 4.92 ± 0.80 5.22 ± 0.85 40.36 ± 10.66 39.31 ± 7.65
Glyburide 0.05 5.07 ± 1.04 4.74 ± 0.89 42.46 ± 10.94 38.56 ± 9.02
Distilled water 20ml 5.15 ± 0.99 5.42 ± 0.85 42.04 ± 10.05 41.32 ± 9.94
Two batches:
Happy (height) 6.00 5.10 ± 1.03 4.90 ± 0.82 19.60 ± 3.74 23.6 ± 5.23 of blood sugar lowering
Happy (low) 0.60 5.21 ± 1.22 5.44 ± 1.11 17.64 ± 5.73 17.81 ± 5.03 of blood sugar lowering
Plant medicated powder (height) 4.40 4.76 ± 0.78 4.23 ± 1.24 20.91 ± 4.15 21.22 ± 9.06
Plant medicated powder (low) 0.44 5.30 ± 0.93 4.91 ± 0.66 18.31 ± 2.96 19.17 ± 3.77
Animal medicated powder (height) 1.56 4.63 ± 1.25 4.23 ± 0.98 18.53 ± 4.14 19.34 ± 3.66
Animal medicated powder (low) 0.16 5.15 ± 1.27 5.44 ± 1.08 18.55 ± 1.96 18.47 ± 3.50
Glyburide 0.05 4.87 ± 1.28 3.20 ± 1.06* 20.66 ± 4.43 25.00 ± 5.61*
Distilled water 20ml 4.51 ± 1.72 4.63 ± 1.29 18.11 ± 3.85 19.80 ± 4.93
Compare * P<0.05 with blank group (distilled water group)
Table 4 blood sugar lowering pleasure is to the influence of normal rat carbohydrate tolerance (n=10 X ± SD)
Dosage carbohydrate tolerance (blood glucose mmol/L)
120min behind the 60min medicine behind the 20min medicine behind the g/kg medicine
A collection of
Happy (height) 6.00 7.16 ± 2.03 6.22 ± 1.65 4.21 ± 1.34* of blood sugar lowering
Happy (low) 0.60 7.70 ± 2.62 6.98 ± 2.49 4.94 ± 2.14 of blood sugar lowering
Plant medicated powder (height) 4.40 7.35 ± 2.05 6.52 ± 1.64 4.61 ± 1.58*
Plant medicated powder (low) 0.44 7.65 ± 2.26 6.88 ± 2.19 5.07 ± 0.19
Animal medicated powder (height) 1.56 7.96 ± 2.11 6.73 ± 1.26 5.08 ± 0.15
Animal medicated powder (low) 0.16 7.76 ± 2.13 6.88 ± 1.50 5.55 ± 0.14
Glyburide 0.05 6.84 ± 2.92 5.79 ± 2.25 4.67 ± 2.05*
Distilled water 20.0ml 8.28 ± 2.68 6.88 ± 2.00 6.60 ± 1.80
Two batches
Happy (height) 6.00 7.91 ± 1.44 9.23 ± 2.76 8.71 ± 3.67 of blood sugar lowering
Happy (low) 0.60 9.33 ± 2.93 9.65 ± 2.84 9.53 ± 2.11 of blood sugar lowering
Plant medicated powder (height) 4.40 8.34 ± 2.19 9.60 ± 1.67 8.86 ± 2.08
Plant medicated powder (low) 0.44 9.66 ± 2.39 10.91 ± 1.77 9.43 ± 2.47
Animal medicated powder (height) 1.56 8.78 ± 3.08 9.99 ± 2.18 9.04 ± 1.83
Animal medicated powder (low) 0.16 9.83 ± 2.55 11.11 ± 1.85 9.56 ± 2.07
Glyburide 0.05 7.44 ± 3.26 8.50 ± 2.71**, 7.50 ± 2.31**
Distilled water 20.0ml 11.05 ± 5.43 12.96 ± 3.88 11.42 ± 3.56
Compare * P<0.05 * * P<0.01 * * * P<0.001 with blank group contrast (distilled water group)
Table 5 blood sugar lowering pleasure is to the influence of hyperglycemia mouse blood sugar (n=10, X ± SD)
Dosage blood glucose (mmol/L)
Before the g/kg moulding behind the moulding 48h medicine 10 days
A collection of:
Happy (height) 6.00 5.28 ± 0.75 17.99 ± 2.59 12.46=4.2* of blood sugar lowering
Happy (low) 0.60 5.02 ± 1.01 19.47 ± 2.18 14.82=2.76 of blood sugar lowering
Plant medicated powder (height) 4.40 4.51 ± 0.86 18.39 ± 2.78 12.32=3.92**
Plant medicated powder (low) 0.44 5.41 ± 0.74 17.91 ± 2.75 11.48=5.02**
Animal medicated powder (height) 1.56 5.38 ± 0.74 17.36 ± 3.02 11.73=4.34**
Animal medicated powder (low) 0.16 5.28 ± 1.18 17.93 ± 2.54 15.24=3.93
Insoral 0.10 5.35 ± 0.68 18.31 ± 2.52 10.76=1.92**
Moulding contrast water 20ml 5.39 ± 1.09 19.66 ± 3.39 17.37=4.62
Distilled water water 20ml 5.19 ± 1.10 5.19 ± 0.74 5.31=0.74
Two batches:
Happy (height) 6.00 5.10 ± 1.00 19.50 ± 3.06 13.71=3.31*** of blood sugar lowering
Happy (low) 0.60 5.11 ± 1.00 19.36 ± 3.66 16.90=2.81 of blood sugar lowering
Plant medicated powder (height) 4.40 5.63 ± 0.77 20.51 ± 4.80 14.20=1.21***
Plant medicated powder (low) 0.44 5.41 ± 0.99 19.77 ± 3.13 18.31=3.64
Animal medicated powder (height) 1.56 5.60 ± 1.34 19.14 ± 3.34 15.91=2.21*
Animal medicated powder (low) 0.16 5.61 ± 0.74 19.83 ± 2.76 19.22=3.11
Insoral 0.10 5.33 ± 1.14 19.97 ± 2.68 11.34=2.23***
Moulding contrast water 20ml 5.60 ± 1.22 19.65 ± 4.05 20.17=5.28
Distilled water 20ml 5.10 ± 1.11 5.23 ± 1.10 5.50=0.95
Compare * P<0.05 * * P<0.01 * * * P<0.001 with the moulding matched group
Table 6 blood sugar lowering pleasure is to the influence of the plain level of hyperglycemia mouse islets (n=10, X ± SD)
Dosage insulin (IU/L)
Before the g/kg moulding behind the moulding 48h medicine 10 days
A collection of:
Happy (height) 6.00 17.81 ± 2.02 3.38 ± 0.76 5.98 ± 1.56** of blood sugar lowering
Happy (low) 0.60 16.13 ± 2.42 3.84 ± 0.68 4.34 ± 1.04 of blood sugar lowering
Plant medicated powder (height) 4.40 16.93 ± 2.07 3.82 ± 1.11 6.70 ± 3.02
Plant medicated powder (low) 0.44 17.00 ± 3.21 3.83 ± 0.86 4.99 ± 1.83
Animal medicated powder (height) 1.56 17.30 ± 2.38 3.59 ± 0.79 4.88 ± 1.01
Animal medicated powder (low) 0.16 16.74 ± 2.52 3.45 ± 0.96 4.45 ± 0.90
Insoral 0.10 17.51 ± 1.95 3.79 ± 1.18 7.10 ± 0.83**
Moulding contrast water 20ml 16.11 ± 2.71 3.25 ± 0.74 4.04 ± 1.12
Distilled water 20ml 17.43 ± 3.09 17.68 ± 2.18 16.99 ± 1.74
Two batches:
Happy (height) 6.00 18.60 ± 2.91 5.00 ± 0.83 8.71 ± 1.11*** of blood sugar lowering
Happy (low) 0.60 18.34 ± 2.22 4.93 ± 1.12 7.11 ± 2.40*** of blood sugar lowering
Plant medicated powder (height) 4.40 17.80 ± 2.81 4.90 ± 1.11 6.22 ± 1.54**
Plant medicated powder (low) 0.44 18.33 ± 3.07 4.93 ± 0.99 5.43 ± 0.99
Animal medicated powder (height) 1.56 17.11 ± 3.13 5.14 ± 1.68 6.14 ± 1.89
Animal medicated powder (low) 0.16 19.54 ± 2.34 5.22 ± 1.19 5.95 ± 1.58
Insoral 0.10 18.00 ± 2.70 5.11 ± 1.43 10.02 ± 2.34***
Moulding contrast water 20ml 18.60 ± 2.61 5.00 ± 1.33 4.61 ± 1.11
Distilled water 20ml 18.51 ± 2.56 18.02 ± 2.04 17.66 ± 2.63
Table 7 blood sugar lowering pleasure is to the influence of hyperglycemia mice carbohydrate tolerance (n=10, X ± SD)
Dosage carbohydrate tolerance (blood glucose mmol/L)
120min behind the 60min medicine behind the 20min medicine behind the g/kg medicine
A collection of
Happy (height) 6.00 13.40 ± 4.74*** 11.86 ± 1.33** of blood sugar lowering 8.99 ± 3.64**
Happy (low) 0.60 17.69 ± 3.37 14.65 ± 3.17 12.36 ± 2.43* of blood sugar lowering
Plant medicated powder (height) 4.40 14.91 ± 3.34** 12.86 ± 5.03* 10.24 ± 4.21**
Plant medicated powder (low) 0.44 15.83 ± 2.89** 13.80 ± 4.62 12.51 ± 2.47*
Animal medicated powder (height) 1.56 15.94 ± 2.83** 13.23 ± 4.37* 4.38 ± 3.35**
Animal medicated powder (low) 0.16 19.27 ± 3.73 14.82 ± 5.23 12.87 ± 3.54
Insoral 0.10 12.86 ± 3.38** 10.80 ± 3.74** 7.40 ± 2.05**
Moulding contrast water 20.0ml 20.04 ± 3.51 17.43 ± 4.44 13.27 ± 3.49
Distilled water 20ml 8.27 ± 2.10 7.41 ± 1.90 6.92 ± 2.16
Two batches
Happy (height) 6.00 17.50 ± 1.73** 13.91 ± 2.94*** of blood sugar lowering 13.85 ± 2.51***
Happy (low) 0.60 19.22 ± 2.94 18.11 ± 2.46* 17.64 ± 1.83 of blood sugar lowering
Plant medicated powder (height) 4.40 18.24 ± 3.11 17.91 ± 2.20**, 14.50 ± 2.33***
Plant medicated powder (low) 0.44 19.40 ± 2.61 18.53 ± 2.25* 17.20 ± 2.14
Animal medicated powder (height) 1.56 18.50 ± 2.67 18.23 ± 2.41*, 16.27 ± 1.95***
Animal medicated powder (low) 0.16 19.73 ± 3.09 18.84 ± 2.07 17.55 ± 1.73
Insoral 0.15 13.90 ± 2.91*** 12.70 ± 1.87*** 10.60 ± 2.61***
Moulding contrasts little 20.0ml 20.66 ± 2.21 20.70 ± 1.87 18.77 ± 1.85
Distilled water 20ml 8.10 ± 1.20 7.93 ± 1.32 7.45 ± 1.24
Table 8 blood sugar lowering pleasure is to the influence of hyperglycemic rat blood glucose (n=10, X ± SD)
Dosage blood glucose (mmol/L)
Before the g/kg moulding behind the moulding 48h medicine 10 days
A collection of
Happy (height) 6.00 6.12 ± 1.14 18.87 ± 2.85 13.11 ± 2.31* of blood sugar lowering
Happy (low) 0.60 6.22 ± 1.13 18.29 ± 3.01 14.65 ± 1.18 of blood sugar lowering
Plant medicated powder (height) 4.40 5.55 ± 1.13 19.47 ± 2.22 12.63 ± 3.10*
Plant medicated powder (low) 0.44 5.81 ± 1.72 19.70 ± 3.33 15.66 ± 2.54
Animal medicated powder (height) 1.56 5.84 ± 1.43 17.90 ± 2.64 13.00 ± 3.79*
Animal medicated powder (low) 0.16 5.65 ± 1.15 18.45 ± 2.41 15.26 ± 2.55
Insoral 0.10 6.34 ± 1.33 18.08 ± 4.87 11.28 ± 2.57**
Moulding contrast water 20.0ml 5.74 ± 1.02 17.99 ± 3.39 16.51 ± 3.25
Distilled water 20ml 5.53 ± 0.87 5.69 ± 1.30 5.65 ± 1.23
Two batches
Happy (height) 6.00 5.41 ± 0.55 20.60 ± 3.23 15.77 ± 4.70** of blood sugar lowering
Happy (low) 0.60 5.22 ± 0.64 20.11 ± 2.94 18.30 ± 4.33 of blood sugar lowering
Plant medicated powder (height) 4.40 5.24 ± 0.66 20.10 ± 3.44 15.90 ± 4.40**
Plant medicated powder (low) 0.44 5.24 ± 0.55 19.30 ± 3.07 18.22 ± 2.76
Animal medicated powder (height) 1.56 5.25 ± 0.50 20.00 ± 2.46 17.11 ± 3.03*
Animal medicated powder (low) 0.16 5.30 ± 0.44 19.11 ± 2.87 19.05 ± 4.04
Insoral 0.10 5.47 ± 0.73 19.71 ± 5.18 15.83 ± 3.81***
Moulding contrast water 20.0ml 5.30 ± 0.77 20.50 ± 1.68 20.24 ± 2.16
Distilled water 20ml 5.33 ± 0.78 5.33 ± 0.83 5.35 ± 1.13
Compare * P<0.05 * * P<0.01 * * * P<0.001 with moulding
Table 9 blood sugar lowering pleasure is to the influence of hyperglycemic rat insulin (n=10, X ± SD)
Dosage insulin (IU/L)
Before the g/kg moulding behind the moulding 48h medicine 10 days
A collection of
Happy (height) 6.00 17.26 ± 2.52 3.96 ± 0.81 6.44 ± 1.41** of blood sugar lowering
Happy (low) 0.60 17.37 ± 2.03 3.65 ± 1.03 5.19 ± 1.73** of blood sugar lowering
Plant medicated powder (height) 4.40 16.73 ± 2.02 3.45 ± 0.89 6.60 ± 1.33**
Plant medicated powder (low) 0.44 17.49 ± 2.40 3.66 ± 1.62 5.14 ± 0.99**
Animal medicated powder (height) 1.56 16.24 ± 1.63 3.67 ± 0.99 5.36 ± 1.40**
Animal medicated powder (low) 0.16 16.44 ± 2.40 3.25 ± 0.69 4.70 ± 0.75**
Insoral 0.10 17.08 ± 2.79 3.55 ± 0.87 8.23 ± 1.57**
Moulding contrast water 20.0ml 17.33 ± 3.22 3.83 ± 0.87 3.25 ± 0.80
Distilled water 20ml 17.83 ± 1.94 17.04 ± 2.53 17.32 ± 2.63
Two batches
Happy (height) 6.00 18.60 ± 3.11 5.53 ± 1.76 9.66 ± 1.52*** of blood sugar lowering
Happy (low) 0.60 18.15 ± 2.93 4.89 ± 0.87 7.90 ± 2.20*** of blood sugar lowering
Plant medicated powder (height) 4.40 17.83 ± 2.36 5.27 ± 1.13 8.70 ± 1.83***
Plant medicated powder (low) 0.44 18.77 ± 3.24 5.06 ± 1.28 7.50 ± 2.73*
Animal medicated powder (height) 1.56 18.33 ± 2.36 4.78 ± 1.36 6.60 ± 1.85*
Animal medicated powder (low) 0.16 18.56 ± 2.87 5.06 ± 1.26 5.66 ± 2.07
Insoral 0.10 19.40 ± 2.46 5.16 ± 1.07 10.31 ± 2.93**
Moulding contrast water 20.0ml 18.44 ± 2.93 5.00 ± 1.34 5.07 ± 1.15
Distilled water 20ml 19.17 ± 4.08 20.11 ± 2.59 18.66 ± 2.83
Table 10 blood sugar lowering pleasure is to the influence of hyperglycemic rat carbohydrate tolerance (n=10, X ± SD)
Dosage carbohydrate tolerance (blood glucose mmol/L)
120min behind the 60min medicine behind the 20min medicine behind the g/kg medicine
A collection of
Happy (height) 6.00 13.29 ± 2.45*** 11.74 ± 2.11*** of blood sugar lowering 10.38 ± 2.05***
Happy (low) 0.60 15.00 ± 2.88*** 14.14 ± 2.22*** of blood sugar lowering 12.63 ± 1.17***
Plant medicated powder (height) 4.40 14.42 ± 3.08*** 13.69 ± 2.24*** 11.78 ± 2.10***
Plant medicated powder (low) 0.44 14.93 ± 2.54*** 13.98 ± 1.98*** 13.04 ± 1.20***
Animal medicated powder (height) 1.56 16.38 ± 2.97 15.35 ± 2.22*, 13.64 ± 1.62*
Animal medicated powder (low) 0.16 17.20 ± 0.39 15.83 ± 3.63* 14.46 ± 3.07
Insoral 0.10 11.20 ± 5.21*** 10.23 ± 4.27*** 8.59 ± 3.55***
Moulding contrast water 20.0ml 19.26 ± 3.39 18.34 ± 3.18 15.94 ± 2.72
Distilled water 20ml 8.28 ± 2.68 6.88 ± 2.01 6.60 ± 1.84
Two batches
Happy (height) 6.00 16.55 ± 2.10*** 16.13 ± 2.44*** of blood sugar lowering 15.00 ± 2.11***
Happy (low) 0.60 18.00 ± 3.64** 18.64 ± 2.72* of blood sugar lowering 16.20 ± 2.13**
Plant medicated powder (height) 4.40 18.71 ± 2.95* 16.43 ± 2.42*** 15.93 ± 2.92**
Plant medicated powder (low) 0.44 19.33 ± 2.56* 17.82 ± 3.55*** 17.00 ± 2.14
Animal medicated powder (height) 4.56 18.81 ± 3.20* 17.05 ± 3.26** 16.14 ± 2.93*
Animal medicated powder (low) 0.16 19.35 ± 3.46 18.54 ± 3.28* 17.39 ± 2.48
Insoral 0.10 15.77 ± 4.53*** 14.84 ± 2.03*** 14.06 ± 1.67***
Moulding contrasts little 20.0ml 21.76 ± 2.66 21.49 ± 2.95 18.95 ± 2.86
Distilled water 20ml 11.02 ± 5.48 12.98 ± 3.83 11.44 ± 3.57
Compare * P<0.05 * * P<0.01 * * * P<0.001 with matched group
C. brief summary
To normal mouse, the happy and plant amedica part of blood sugar lowering, the animal drugs part blood glucose insulin level that all can not raise can not improve carbohydrate tolerance, can not blood sugar lowering content, but can use a large amount of after obvious raising carbohydrate tolerance during 120min.To alloxan hyperglycemia mice, the happy and plant part of blood sugar lowering can obviously reduce the plain level in island, blood sugar lowering is happy, the plant amedica part, and the animal drugs part obviously blood sugar lowering content, obviously increase carbohydrate tolerance.To the alloxan hyperglycemic rat, blood sugar lowering pleasure and plant amedica thereof, animal drugs part all can obviously increase insulin level, improve carbohydrate tolerance, blood sugar lowering level.
2. toxicity test
Medicine of the present invention carried out the acute toxicity test of white mice in 1994 through the institute for drug control, Guangxi, conclusion be " this product toxicity is low; fail to measure its LD50, and the maximum tolerated dose that mice gavages this product is greater than the quite clinical plan of this dosage of 30g/kg(600 times with daily dose).”
3, clinical trial
In JIUYUE, 1994-November, first Affiliated Hospital of Colleges Of Traditional Chinese Medicine Of Guangxi, second Affiliated Hospital, No.1 Hospital Attached to Guangxi Medical Univ. carries out clinical trial to diabetics, treatment group and contrast be totally 160 examples, 60 examples are observed by one attached institute of Colleges Of Traditional Chinese Medicine Of Guangxi, 60 examples are observed by two attached institutes of Colleges Of Traditional Chinese Medicine Of Guangxi, and 40 examples are observed by one attached institute of Guangxi Medical University.
A. physical data
The object of observation of being included in is 18-65 year, meets the diabetics of WHO tentative standard in 1980.100 examples are organized in treatment, use the happy capsule of blood sugar lowering, and matched group 60 examples are used Guangxi Medical Univ. Pharmaceutical Plant's production XIAOKE JIANGTANG JIAONANG, and treatment group and matched group sex, age distribution all do not have significant difference (P>0.05), see Table 11.
B. diagnostic criteria:
(1) the Western medicine diagnose standard adopts WHO tentative standard (venous plasma method) in 1980, allly meets that one of following condition person is diagnosable to be diabetes:
(1) diabetic symptom is arranged, any time blood glucose 〉=11.1mmol/L(200mg/dl), or fasting blood 〉=7.8mmol/L(149mg/dl).
(2) diabetic symptom is arranged and blood glucose does not reach above-mentioned standard, carry out 75g oral glucose tolerance test (OGTT), 2 hours blood glucose 〉=11.1mmol/L(200mg/dl).
(3) as the non-diabetic symptom, except that above-mentioned standard, add a standard in addition, be OGTT1 hour blood glucose 〉=11.1mmol/L(200mg/dl), or another time OGTT2 hour blood glucose 〉=11.1mmol/L(200mg/dl), or another time fasting blood 〉=7.8mmol/L(140mg/dl).
(2) tcm diagnosis standard; All have a thirsty polydipsia, and rapid digestion of food is easily hungry, and frequent micturition and sweet, body see that gradually patient such as become thin can make a definite diagnosis.
C. observational technique
Observe 160 examples altogether, be divided into 2 groups at random, 100 examples are organized in treatment, use the happy capsule of blood sugar lowering, each 4, every day 3 times, serve on for 4 weeks.Matched group 60 examples, the XIAOKE JIANGTANG JIAONANG of using Guangxi Medical Univ. Pharmaceutical Plant to produce, each 5,2 hours ante cibum warm water delivery service, every day 3 times, 4 weeks of logotype.Conventional before the test experimenter is made detailed physical examination, surveys fasting glucose, glucose in urine (treat preceding 4 weeks, surveyed fasting glucose, glucose in urine 1 time every 10 days, continuous 3 times, with 3 averages as treating preceding control value).Weekly with examining 1 time, inquire the situation of taking medicine after the test, 1 empty stomach and 2 hours after the meal blood glucose are surveyed in the record state of an illness and side effect.The variation of traditional Chinese medical science witness is evaluated with scoring method, and the curative effect judgement is directly made by the observer.Viewing duration is generally without other similar medicines, to the insulin patient of difficulty recklessly that stops using, can observe the therapeutic effect after the decrement.
D. result
Efficacy assessment standard:
(1) produce effects: treatment back symptom disappears substantially, fasting glucose<7.2mmol/L(130mg/dl), 2 hours after the meal blood glucose<8.3mmol/L(150mg/dl), twenty-four-hour urine sugar quantitatively<10.0g; Or blood glucose, twenty-four-hour urine sugar quantitatively descends more than 30% before the treatment.
(2) effective: treatment back symptom is obviously improved, fasting glucose<8.3mmol/L(150mg/dl), 2 hours after the meal blood glucose<10.0mmol/L(180mg/dl), twenty-four-hour urine sugar quantitatively<25.mg; Or blood glucose, twenty-four-hour urine sugar sugar quantitatively descends more than 10% before the treatment; Or use and can reduce insulin dosage behind this medicine and keep fasting glucose<7.2mmol/L, 2 hours after the meal blood glucose<8.3mmol/L, twenty-four-hour urine sugar quantitatively<10.0g.
(3) invalid: treatment back symptom does not have obvious improvement, and blood glucose, glucose in urine descend and do not reach above-mentioned standard.
Therapeutic outcome:
(1) compares before and after the treatment of witness integration: see Table 12.
(2) compare before and after the physico-chemical examination treatment: see Table 13.
(3) treatment group and matched group are treated relatively: see Table 14.
Table 11 treatment group and matched group sex, age ratio are
The sex age
Men and women's age bracket X ± SD
56 44 42-65 50.39 ± 10.78 are organized in treatment
Matched group 31 29 32-65 50.12 ± 10.98
Table 12 compares (X=SD) before and after seeing the treatment of disease integration
Treatment group matched group
After treating before the preceding treatment of the n treatment back n treatment
Thirsty polydipsia 100 4.53 ± 1.06 1.68 ± 1.07 60 4.41 ± 1.04 2.01 ± 1.19
Polyorexia 100 4.24 ± 1.05 1.53 ± 1.21 60 3.97 ± 1.24 1.80 ± 1.22
Urinary micturition 100 4.44 ± 1.53 2.16 ± 1.15 60 4.45 ± 1.30 1.99 ± 1.13
Emaciated physique 82 3.39 ± 1.26 2.84 ± 1.12 38 3.12 ± 1.16 2.81 ± 1.19
Annotate: relatively, the P value all<0.01 before and after the treatment
Compare (Ridit analysis) before and after the table 13 physico-chemical examination treatment
Treatment group matched group
After treating before the preceding treatment of the n treatment back n treatment
Fasting glucose 100 10.86 ± 2.18 7.71 ± 2.12 60 11.00 ± 2.35 6.83 ± 2.58
2h blood glucose 96 13.57 ± 2.66 10.53 ± 2.36 57 13.37 ± 2.50 10.53 ± 4.12 after the meal
Annotate: relatively, the P value all<0.01 before and after the treatment
Table 14 treatment group and matched group curative effect be (Ridit analysis) relatively
N produce effects enabledisable R U P
Treatment organizes 100 32 48 20 0.4758
1.0267 >0.05
Treatment back 60 25 23 12 0.5242
E. side effect
100 examples are organized in treatment, and matched group 60 examples are not all found obvious adverse reaction and toxic and side effects at viewing duration.
F. discuss and sum up
(1) the happy capsule of blood sugar lowering has certain therapeutic effect to diabetes, the thirsty polydipsia of energy control of diabetes patient after the medication, and polyorexia, clinical symptoms such as urinary micturition point out this medical instrument to have the supplementing QI for promoting the production of body fluid spleen invigorating to moisturize, and grow lung and reinforce the kidney the effect of nourishing YIN to lower pathogenic fire.(seeing Table 12).
(2) this organizes 100 examples, matched group 60 examples, treatment back patient's fasting glucose and after the meal 2h blood glucose obvious decline (P<0.01 sees Table 12) is all arranged, the happy capsule of prompting blood sugar lowering can control of diabetes patient blood glucose.
(3) this organizes 100 examples, and total effective rate is 80%.Matched group 60 examples, total effective rate are 80%.Two groups are compared no significant difference (P>0.05 sees Table 14).
(4) this product is safe and reliable, no obvious adverse reaction and toxic and side effects.
In JIUYUE, 1994 to November first Affiliated Hospital of Colleges Of Traditional Chinese Medicine Of Guangxi the happy capsule of new drug blood sugar lowering has been carried out clinical verification:
A. clinical data
Accept diabetics 60 examples for medical treatment.30 examples are organized in treatment, use the happy capsule of blood sugar lowering, inpatient's 7 examples wherein, outpatient service 23 examples.Matched group 30 examples: the XIAOKE JIANGTANG JIAONANG of using Guangxi Medical Univ. Pharmaceutical Plant to produce, wherein inpatient's 7 examples: outpatient service 23 examples.Two groups of sexes, age distribution do not have significant difference (P>0.05).See Table 15.
Case selection, diagnostic criteria, observational technique, curative effect judging standard and statistical procedures method are all carried out according to proof scheme.
B. therapeutic outcome
(1) to the influence of various symptoms, sign: see Table 16.
(2) to the influence of blood glucose: see Table 16.
Table 15 treatment group and matched group sex, age ratio are
The sex age
Routine number divides into groups
Men and women X ± SD minimax
Treatment organizes 30 15 15 54.2 ± 11.1 65 42
Matched group 30 17 13 54.57 ± 9.36 65 32
Annotate: two groups of sexes, distributions are compared, and P all>0.05
Table 16 compares (X before and after seeing the treatment of disease integration
-± SD)
Treatment group matched group
See disease and blood glucose
After treating before the preceding treatment of the n treatment back n treatment
Thirsty polydipsia 30 4.93 ± 1.14 2.18 ± 1.38* 30 4.32 ± 0.96 2.59 ± 1.37*
Polyorexia 30 4.13 ± 0.90 1.47 ± 1.28* 30 3.43 ± 0.98 2.15 ± 1.12
Urinary micturition 30 4.33 ± 1.06 2.26 ± 1.14* 30 4.46 ± 1.45 2.13 ± 1.24
Emaciated physique 24 3.25 ± 1.54 2.25 ± 1.22 24 2.96 ± 1.31 2.42 ± 1.18
Fasting glucose 30 9.16 ± 1.82 7.95 ± 1.91** 30 9.0 ± 1.64 8.2 ± 2.3
(mmol/L)
Post-prandial glycemia 26 14.28 ± 2.28 11.2 ± 2.07 27 13.36 ± 2.35 12.33 ± 5.21
(mmol/L)
Annotate: front and back relatively, * represents<0.01, * * represents P<0.05, all the other represent P>0.05
The comparison of (3) treatment group and matched group curative effect: see Table 17.
Table 17 treatment group and matched group curative effect be (Ridit analysis) relatively
Routine digital display effect enabledisable total effective rate R U P divides into groups
Treat 30 10 16 4 86.67% 0.5278
0.7459 >0.05
Contrast 30 10 11 9 70% 0.4722
Annotate: two groups of curative effect of medication do not have significant difference (P>0.05)
C. discuss and brief summary
(1) the happy capsule of blood sugar lowering has supplementing QI for promoting the production of body fluid, spleen invigorating and moisturizes, grows that lung reinforces the kidney, the effect of nourishing YIN to lower pathogenic fire, can significantly improve clinical symptoms such as the common thirsty polydipsia of diabetics, polyorexia, urinary micturition, simultaneously the unusual higher fasting blood of diabetics and 2 hours after the meal blood glucose also there is tangible reduction effect, this clinical verification total effective rate is 86.67%, and curative effect and matched group do not have significant difference.
(2) the happy capsule formulation of blood sugar lowering is reasonable, and taking convenience is safe and reliable, does not see obvious adverse reaction.
In sum, this medicine meets new drug safety, effectively requirement.
4, model case:
Example 1, Zhang, male 38 years old.Because of thirsty, polydipsia, fatigue and weakness 1 year were gone to a doctor on October 20th, 1994.Card is seen: thirst and liking drink, and fatigue and weakness, spontaneous sweating, breathe hard lazy speech, dysphoria with feverish sensation in the chest palms and soles, palpitation and insomnia, constipation, corpulent tongue is big, thin fur, thready and rapid pulse.Fasting glucose 13.96mmol/L, 2h blood glucose 12.85mmol/L after the meal.Tcm diagnosis: diabetes (syndrome of deficiency of both qi and yin).Western medicine diagnose: diabetes (II type).Give the happy capsule of blood sugar lowering, each 4, every day 3 times.Take medicine after 1 week, thirst and liking drink, dysphoria with feverish sensation in the chest palms and soles, diseases such as cardiopalmus, insomnia are obviously improved.Symptom disappears substantially after 4 weeks.Fasting glucose 6.45mmol/L, 2h blood glucose 660mmol/L after the meal, efficacy evaluation: produce effects.
Example 2, the week * *, the man, 54 years old, because of " polydipsia polyuria repeatedly 5 years companion fatigue and weakness February " in JIUYUE in 1994 prescription on individual diagnosis on the 20th.Readme: thirst and liking drink, urinary micturition, polyorexia, breathe hard lazy speech, dysphoria with feverish sensation in the chest palms and soles, palpitation and insomnia.Inspection is seen: emaciated physique, spiritlessness and weakness, red tongue, yellow and thin fur, stringy and thready pulse.Control 3 times that the fasting glucose average is 8.5mmol/L, mean blood glucose was 12.8mmol/L in 3 times 2 hours after the meal.Tcm diagnosis: quench one's thirst (type of deficiency of both QI and YIN).Western medicine diagnose: non-insulin-dependent diabetes mellitus.Give the happy capsule for treating of blood sugar lowering, every day 3 times, each 4.After 1 week of medication, polyuria begins to alleviate, and fasting glucose is 8.2mmol/L, 2 hours after the meal blood glucose 8.8mmol/L.To the 3rd week, thirsty, polyphagia, easy hungry the alleviation; Fasting glucose 8.1mmol/L, 2 hours after the meal blood glucose 8.5mmol/L.To the 4th week, disappearances such as polydipsia polyuria, only surplus slight easily famine and emaciated physique symptom, check fasting glucose 7.23mmol/L, 2 hours after the meal blood glucose 7.8mmol/L, efficacy evaluation: produce effects.
Claims (5)
1, a kind of Chinese medicine for the treatment of diabetes is characterized in that Main Ingredients and Appearance is: pancreas of pig or cattle, sheep and Fructus Momordicae charantiae, Fructus Cucurbitae moschatae, the Radix Astragali, Rhizoma Dioscoreae.
2, Chinese medicine according to claim 1 is characterized in that each composition of this Chinese medicine by the weight % content of dried medical material is:
The pancreas 20-45 of pig or cattle, sheep
Fructus Momordicae charantiae 18-32
Rhizoma Dioscoreae 10-28
Fructus Cucurbitae moschatae 15-25
Radix Astragali 10-26
3, a kind of production method for the treatment of the Chinese medicine of diabetes, it is characterized in that earlier the pancreas of pig or cattle, sheep is rubbed, drying under reduced pressure is pulverized the composition end again, and is standby, other gets, and the water extract of Fructus Momordicae charantiae, Fructus Cucurbitae moschatae, the Radix Astragali or alcohol are analysed the Rhizoma Dioscoreae of thing, dry expanded pulverizing and pig or cattle, the Pancreas caprae seu ovis powder mixes is even, add antiseptic and mix, low-temperature reduced-pressure drying and crushing, sterilization, make tablet, capsule or unguentum.
4, the production method of Chinese medicine according to claim 3, the water extract that it is characterized in that Fructus Momordicae charantiae, Fructus Cucurbitae moschatae, the Radix Astragali is earlier dried Frutus Momordicae Charantiae, dried pumpkin, the Radix Astragali to be mixed, add 5-6 times of water, soaked 4-8 hour, decoct secondary, each 1 hour, collecting decoction, filter, filtrate is evaporated to the clear paste that relative density is 1.2-1.4 50-80 ℃ temperature.
5, the production method of Chinese medicine according to claim 3, it is that Fructus Momordicae charantiae, Fructus Cucurbitae moschatae, the Radix Astragali are mixed chopping that the alcohol that it is characterized in that Fructus Momordicae charantiae, Fructus Cucurbitae moschatae, the Radix Astragali is analysed thing, with alcohol solution dipping 4-10 hour of 2-3 70-80% doubly, the solution that leaches steams ethanol, obtains the solution I, and filtering residue was with 2 times of water boils 1 hour, discard residue, obtain the solution II, solution I and solution II are merged, be evaporated to the clear paste that relative density is 1.2-1.4.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 95103732 CN1112439A (en) | 1995-04-17 | 1995-04-17 | Chinese medicine for diabetes and its preparation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 95103732 CN1112439A (en) | 1995-04-17 | 1995-04-17 | Chinese medicine for diabetes and its preparation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1112439A true CN1112439A (en) | 1995-11-29 |
Family
ID=5074833
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 95103732 Pending CN1112439A (en) | 1995-04-17 | 1995-04-17 | Chinese medicine for diabetes and its preparation |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1112439A (en) |
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1069534C (en) * | 1998-04-22 | 2001-08-15 | 徐光明 | Preparation method for medicine of reducing blood sugar using natural bitter gourd extract |
| CN1090488C (en) * | 2000-06-14 | 2002-09-11 | 邓开仲 | Pharmaceutical for treating diabetes, and its prepn. process |
| CN101129604B (en) * | 2007-08-31 | 2010-05-26 | 哈尔滨医科大学 | A kind of preparation method of hypoglycemic traditional Chinese medicine |
| CN101380105B (en) * | 2008-09-18 | 2011-11-09 | 何官平 | Health care food for diabetic |
| CN102987409A (en) * | 2012-12-20 | 2013-03-27 | 安国市金木生物科技有限公司 | Health-care food for diabetes patient, and preparation method thereof |
| CN103830496A (en) * | 2014-02-28 | 2014-06-04 | 廊坊市思科农业技术有限公司 | Blood glucose reduction resistant composition |
| CN104522826A (en) * | 2014-12-17 | 2015-04-22 | 北京工商大学 | Instant beverage capable of assisting blood sugar reduction and preparation method thereof |
| CN110101020A (en) * | 2018-02-01 | 2019-08-09 | 江苏美中医疗科技有限公司 | A kind of diabetes fully nutrient formula food |
| CN110693990A (en) * | 2019-10-16 | 2020-01-17 | 佳木斯大学 | Medicinal and edible blood sugar reducing granule, and preparation method and application thereof |
-
1995
- 1995-04-17 CN CN 95103732 patent/CN1112439A/en active Pending
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1069534C (en) * | 1998-04-22 | 2001-08-15 | 徐光明 | Preparation method for medicine of reducing blood sugar using natural bitter gourd extract |
| CN1090488C (en) * | 2000-06-14 | 2002-09-11 | 邓开仲 | Pharmaceutical for treating diabetes, and its prepn. process |
| CN101129604B (en) * | 2007-08-31 | 2010-05-26 | 哈尔滨医科大学 | A kind of preparation method of hypoglycemic traditional Chinese medicine |
| CN101380105B (en) * | 2008-09-18 | 2011-11-09 | 何官平 | Health care food for diabetic |
| CN102987409A (en) * | 2012-12-20 | 2013-03-27 | 安国市金木生物科技有限公司 | Health-care food for diabetes patient, and preparation method thereof |
| CN103830496A (en) * | 2014-02-28 | 2014-06-04 | 廊坊市思科农业技术有限公司 | Blood glucose reduction resistant composition |
| CN104522826A (en) * | 2014-12-17 | 2015-04-22 | 北京工商大学 | Instant beverage capable of assisting blood sugar reduction and preparation method thereof |
| CN110101020A (en) * | 2018-02-01 | 2019-08-09 | 江苏美中医疗科技有限公司 | A kind of diabetes fully nutrient formula food |
| CN110693990A (en) * | 2019-10-16 | 2020-01-17 | 佳木斯大学 | Medicinal and edible blood sugar reducing granule, and preparation method and application thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1748765A (en) | Composition with catharsis and toxin expelling, fat reducing and weight reducing function and preparing method | |
| CN1132615C (en) | Health-care product with function of regulating blood sugar and its preparation method | |
| CN1112439A (en) | Chinese medicine for diabetes and its preparation | |
| CN1245198C (en) | Chinese medicine composition for treating diabetes and its preparing method | |
| CN100349598C (en) | Medicine for treating high lipemia and its production method | |
| CN1712048A (en) | Traditional Chinese medicine for treating gas stagnation and stomach pain and preparation method thereof | |
| CN1294936C (en) | Medicine for treating diabetes and its preparation method | |
| CN1663597A (en) | A medicinal composition for invigorating qi and nourishing blood and preparation method thereof | |
| CN1296080C (en) | Liver clearing blood pressure lowering capsule nd its preparation method | |
| CN1323692C (en) | Pharmaceutical composition for treating lumbago due to kidney-asthenia and its preparing process | |
| CN1579455A (en) | Composition of traditional Chinese medicine for large intestine hygropyretic disease and its preparation method | |
| CN1554407A (en) | Medicine for clearing away lung-heat, eliminating phaegn, reliveing cough and asthma and its preparing method | |
| CN1565591A (en) | Preparation and usage of | |
| CN1927312A (en) | Grape extract containing medicine composition and its preparation and use | |
| CN1772189A (en) | Auxiliary treating medicine for lung cancer in late stage | |
| CN1634496A (en) | A kind of traditional Chinese medicine composition for treating diabetes and preparation method thereof | |
| CN1562144A (en) | Chinese medicinal composition for treating intestine irritable syndrome and its preparing method | |
| CN1947747A (en) | Traditional Chinese medicine composition contg. luteolin and capsule of sweeping forsythia and its prepn. method and use | |
| CN101041019A (en) | Traditional Chinese medicinal composition for treating coronary disease and its prepn. method | |
| CN1631418A (en) | A kind of medicine for treating chronic nonspecific ulcerative colitis and its preparation method | |
| CN1628794A (en) | Powder for treating coronary heart disease and angina pectoris and its preparing process | |
| CN1593500A (en) | Kidney benefiting, Chong collateral reinforcing and menstruation regulating hemostat | |
| CN1181089C (en) | Prepn of curcumol and oral medicine containing curcumol | |
| CN1709439A (en) | A Shenqi Jiangtang dripping pill and its preparation and detection method | |
| CN100341490C (en) | Ginseng and astragalis blood glucose lowering dispersion tablet and its preparing and detecting method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C01 | Deemed withdrawal of patent application (patent law 1993) | ||
| WD01 | Invention patent application deemed withdrawn after publication |